Grant
  
      Evaluation of Rac1 Inhibitor 1A-116 on Cancer Progression and Resistance Mechanisms to Molecular Targeted Therapies on Aggressive Tumors
Evaluation of Rac1 Inhibitor 1A-116 on Cancer Progression and Resistance Mechanisms to Molecular Targeted Therapies on Aggressive Tumors